Herpes zoster (HZ) is a common viral disease that mainly affects the elderly population with a rising incidence. The occurrence of postherpetic neuralgia (PHN) is the dominant and thorny complication, which thus further aggravates the disease burden. Vaccination and clinical application of small molecules and biologics for certain diseases are identified as new risk factors for the development of HZ development. HZ vaccination has emerged as a pivotal prevention measure against the occurrence of HZ. Refining the diagnosis and early standardized antiviral treatment of HZ is the key to improve standardized management strategy.
带状疱疹（HZ）是一种常见的病毒性疾病，主要影响老年人群，其发病率呈上升趋势。HZ后神经痛（PHN）是HZ最主要且棘手的并发症，会加重疾病负担。疫苗接种和小分子及生物制剂临床应用成为HZ新的发病风险因素。接种HZ疫苗是预防该病发生的重要举措。细化HZ诊断和早期积极抗病毒治疗是其规范化管理的关键。.